Rite Aid soars on earnings helped by new generics, cost controls - MarketWatch

19-09-2013 MarketWatchComments (0)

Generics

Rite Aid soars on earnings helped by new generics, cost controls
MarketWatch (blog)
Rite Aid said new generic drugs, coupled with higher margins on the front end of its stores as well as expense control helped the company to a gain instead of an expected loss for the second quarter that ended ...

Read more on MarketWatch

Your Comments

Login to add a comment

There are no comments yet. Be the first and leave a response!

Back to top